FW
FOMO WORLDWIDE, INC. (FOMC)·Q2 2022 Earnings Summary
Executive Summary
- Record Q2 2022 revenue of $2.646M, up 2,959% YoY on SST acquisition; gross margin was 8% vs 23% YoY as mix shifted to hardware installs .
- Operating loss narrowed to $(0.253)M and net loss improved to $(1.085)M vs Q1’s $(1.718)M, reflecting scale and lower G&A, while derivative/marketable security marks weighed on other expense .
- Guidance raised: FY22 pro forma revenue to $9–10M (mid $9.5M) from $8–10M (mid $9.0M); management cited sustained K‑12 demand and backlog extending installations into November .
- Liquidity improved with cash $0.234M, AR $1.27M, AR facility $0.73M, deferred revenue $0.825M, and backlog ≈$4M; management targets positive EBITDA in Q3 2022 .
- Potential stock catalysts: raised guidance, backlog visibility, and K‑12 ESSER tailwind vs counterpoints of covenant defaults, derivative liabilities, and going‑concern risk noted in filings .
What Went Well and What Went Wrong
What Went Well
- “Record second quarter results” driven by SST; consolidated revenues hit $2.6M with SST at “record levels,” underpinned by ~$500B K‑12 ESSER stimulus .
- Backlog stability and customer traction: ~95 districts booked covering ~190,000 students; backlog ≈$4M; suppliers provided “head of the line” access amid constraints .
- Guidance raised with pro forma YTD revenue >$6M through August, tracking $9–10M FY22; CEO: “no reason why SST’s business cannot double or triple” as chip shortage normalizes and cross‑sell expands .
What Went Wrong
- Gross margin compressed to 8% in Q2 (vs 13% in Q1 and 23% YoY) as hardware installation mix ramped and cost of sales rose faster than revenue .
- Other expense elevated: interest expense, amortization of debt discount, derivative charges, and marketable security losses drove $(0.832)M other expense in Q2 .
- Financial risk remains: covenant defaults on AR facility (not exercised), significant derivative liabilities ($0.958M), working capital deficit ($1.418M), and going‑concern disclosure .
Financial Results
Segment/Mix (disaggregation of revenue):
Key KPIs and Balance Items (Q2 2022):
Guidance Changes
Notes: Guidance excludes potential M&A impacts under negotiation (no assurances) .
Earnings Call Themes & Trends
(No Q2 earnings call transcript found; themes based on Q1/Q2 10‑Q and Q2 press releases.)
Management Commentary
- John Raymond (SST): “Q2 saw significant gains in booked sales... approximately 95 school districts... backlog continues to hold steady at approximately $4 million... manufacturers ability to rapidly re‑deploy product around... shortage of computer and video chips” .
- Vik Grover (CEO): “The interactive whiteboard market is booming... we will aggressively target additional acquisitions to add to growth and scale. We will now go to the next level” .
- Vik Grover (CEO, guidance PR): “The smart board business is booming in K‑12... cross‑selling new products... edging out into adjacent markets... executing M&A... time to move to the next level and go big.” .
Q&A Highlights
- No earnings call transcript was available; management delivered details via Q2 10‑Q and press releases. Key clarifications include: covenant defaults on AR facility (lender not enforcing) , derivative liabilities/warrants mark‑to‑market , and going‑concern risk with plans to raise capital .
- Liquidity actions: reduction of vendor line, use of AR facility, and improved cash/AR balances to fund operations .
Estimates Context
- Wall Street consensus estimates from S&P Global were unavailable for FOMC due to missing CIQ mapping; therefore, no quantitative comparison to analyst revenue/EPS/EBITDA estimates can be provided at this time.
Key Takeaways for Investors
- Demand/visibility: Raised FY22 revenue guide to $9–10M with YTD pro forma >$6M through August; backlog ≈$4M and installations scheduled through November underpin near‑term revenue recognition .
- Margin trajectory: Gross margin compressed (8% in Q2) as installation-heavy mix scaled; watch mix shift, pricing, and supply chain normalization for margin recovery .
- Operating leverage: Q2 operating loss narrowed materially vs Q1; lower G&A and scale suggest potential leverage if margin improves and derivative/interest burdens moderate .
- Liquidity and risk: Improved cash/AR and funding lines support operations, but covenant defaults, derivative liabilities, working capital deficit, and going‑concern disclosure remain critical risks; financing/dilution likely .
- Execution vector: Cross‑sell (cleantech/IAQ), regional expansion (eastern PA/western OH/MI/NJ), and potential M&A could add scale; monitor deal terms and integration .
- Near‑term trading setup: Guidance raise plus backlog visibility are positive catalysts; offset by margin compression and capital structure complexity—expect volatile microcap trading until financing clarity improves .
- Medium‑term thesis: If K‑12 refresh cycle persists and supply constraints ease, revenue scale with normalized margins and reduced derivative exposure could transition to cash‑flow positivity (management targets Q3 positive EBITDA) .
Citations:
**[867028_0001493152-22-024360_ex99-1.htm:1]** FOMO Corp. 8‑K Exhibit 99.1 (Aug 30, 2022) – Investor meeting, raised guidance
**[867028_0001493152-22-023122_ex99-1.htm:0]** FOMO Corp. 8‑K Exhibit 99.1 (Aug 16, 2022) – Record Q2 results, liquidity, EBITDA outlook
**[867028_0001493152-22-023122_ex99-1.htm:1]** FOMO Corp. 8‑K Exhibit 99.1 (Aug 16, 2022) – John Raymond and CEO quotes, backlog
**[867028_0001493152-22-022732_form10-q.htm:3]** Q2 2022 10‑Q – Balance sheet cash/AR/inventory/deferred revenue
**[867028_0001493152-22-022732_form10-q.htm:4]** Q2 2022 10‑Q – Income statement (sales, GP, Op loss, net loss, EPS)
**[867028_0001493152-22-022732_form10-q.htm:21]** Q2 2022 10‑Q – Revenue disaggregation H1 2022 vs H1 2021
**[867028_0001493152-22-022732_form10-q.htm:31]** Q2 2022 10‑Q – AR credit facility terms and covenant default
**[867028_0001493152-22-022732_form10-q.htm:50]** Q2 2022 10‑Q – MD&A margins and drivers (gross margin %)
**[867028_0001493152-22-022732_form10-q.htm:25]** Q2 2022 10‑Q – Going‑concern discussion and plans
**[867028_0001493152-22-018972_form10-q.htm:3]** Q1 2022 10‑Q – Balance sheet and liquidity baseline
**[867028_0001493152-22-018972_form10-q.htm:4]** Q1 2022 10‑Q – Income statement (sales, GP, losses)
**[867028_0001493152-22-018972_form10-q.htm:10]** Q1 2022 10‑Q – SST business description/ESSER demand
**[867028_0001493152-22-018972_form10-q.htm:20]** Q1 2022 10‑Q – Q1 revenue disaggregation (mix)
**[867028_0001493152-22-018972_form10-q.htm:29]** Q1 2022 10‑Q – AR facility terms
**[867028_0001493152-22-018972_form10-q.htm:39]** Q1 2022 10‑Q – SPA and SST employment/warrants